Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications with specific UK licences: some are approved for type 2 diabetes management (semaglutide [Ozempic], dulaglutide [Trulicity], liraglutide [Victoza]), while others are specifically licensed for weight management in adults with obesity or overweight with weight-related comorbidities (semaglutide [Wegovy], liraglutide [Saxenda])
Expected Results and Realistic Expectations A common question is, "How much weight can you lose on Ozempic in 3 months?" or "How well do weight-loss drugs work?" The answer varies significantly depending on the specific medication, the individual's starting body weight, adherence to the medication regimen and commitment to lifestyle changes
Hallmarks also include an increased chance of cardiovascular disease and diabetes mellitus
Full click-to-mg tables for all 4 pen strengths, the weekly titration schedule and how-to-use steps: Retatrutide Pen Guide
Northwest Face & Body will ensure patients can safely take Ozempic through an in-depth consultation, and the practitioner will help create the best plan for each patient
We will help you plan an exercise regimen that works with your lifestyle, the season, and your goals